Tomonobu Uchino, Daichi Kamiya, Hiroaki Yagi, Hiyori Fujino-Shimaya, Ichiro Hatta, Shun Fujimori, Yasunori Miyazaki, Yukako Kirishita, Yuko Sano, Hajime Mizuno, et al. Comparative analysis of intercellular lipid organization and composition between psoriatic and healthy stratum corneum. Chemistry and physics of lipids. 2023. 254. 105305-105305
Tomonori Tayama, Masatake Ishiuchi, Kenichiro Sugiyama, Yuichi Oka, Hiroshi Maeda, Yoshinori Nagata, Matthew Hruska, Yoshiyuki Kagawa. Safety, Tolerability, and Pharmacokinetics of the Novel Adenosine A 2A Antagonist/Inverse Agonist KW-6356 Following Single and Multiple Oral Administration in Healthy Volunteers. Clinical Pharmacology in Drug Development. 2023
Asami Toshima, Yasuhisa Shiraishi, Daisuke Shinmi, Yoshiyuki Kagawa, Junichi Enokizono. Comprehensive analyses of the intracellular andin vivodisposition of Fab-siRNA conjugate to identify key issues to improve itsin vivoactivity. Drug Metabolism and Disposition. 2022. DMD-AR
Riko Asakawa, Youichi Ogawa, Eri Maejima, Akiko Honobe-Tabuchi, Takashi Okamoto, Hiroshi Mitsui, Yoshiyuki Kagawa, Shinji Shimada, Tatsuyoshi Kawamura. Case of bullous pemphigoid refractory to corticosteroids by antiepileptic drug-induced CYP3A4. The Journal of Dermatology. 2022
Yoshiaki Yamamoto, Yushi Inoue, Naotaka Usui, Katsumi Imai, Yoshiyuki Kagawa, Yukitoshi Takahashi. Therapeutic Drug Monitoring for Rufinamide in Japanese Patients With Epilepsy: Focus on Drug Interactions, Tolerability, and Clinical Effectiveness. Therapeutic drug monitoring. 2022. 44. 4. 585-591